A multicenter study for efficacy of intelligent psychosomatic adjustment system intervention in the treatment of novel coronavirus pneumonia (COVID-19) patients with mild to moderate anxiety and depression

INTERVENTION: Psychological Intervention Group:"Intelligent Psychosomatic Regulation System" Intervention;Control Group :General Treatment ; CONDITION: novel coronavirus pneumonia (COVID‐19) with mild to moderate anxiety and depression PRIMARY OUTCOME: the score of Hamilton depression scale;the score of Hamilton anxiety scale;the score of Self‐Rating Depression Scale;the score of Self‐Rating Anxiety Scale;the score of Athens Insomnia Scale; INCLUSION CRITERIA: 1. Age between 18 and 75 years old (including threshold), regardless of gender; 2. The patient under isolation observation is diagnosed with mild or common type of 2019‐nCoV acute respiratory disease and can cooperate to complete corresponding psychological intervention; 3. The total score of Hamilton depression scale (HAMD17) and Hamilton anxiety scale (HAMA14) at baseline is both at least 7; 4. The patient has sufficient compliance to complete the experiment according to the protocol; 5. The patient and his/her family or guardian sign the informed consent to participate voluntarily in this clinical study.